Minnesota Medical Development, Inc. Newsroom - Profile and News Archive
Engage with Minnesota Medical Development, Inc.
Follow:
Press Releases from Minnesota Medical Development, Inc. :
MMDI Announces Agreement with Novation to Supply the Rebound HRD
MINNEAPOLIS, Minn. (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that it has been awarded an agreement under Novation’s ‘New Medical Technology’ program to supply its Rebound HRD and Rebound HRD V (hernia repair devices) to their alliance members, which includes: acute hospitals and systems, academic medical centers and ambulatory care facilities. The Rebound HRD® and HRD V are intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists.
MMDI’s Rebound HRD V Receives FDA 510(k) Clearance
MINNEAPOLIS, Minn., April 29 (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its new Rebound HRD V (Hernia Repair Device). The Rebound HRD V is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists and where the support of a nonabsorbable material is preferred.
USPTO Issues a Notice of Allowance for MMDI’s BetaWire(TM) Guidewire Patent
MINNEAPOLIS, Minn., Nov. 19 (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the company’s BetaWire(TM) guidewire technology. The BetaWire(TM) is a super-torque interventional guidewire manufactured from a Beta Titanium alloy. Guidewires are thin, flexible wires that are used to facilitate the placement of balloon catheters and other diagnostic and therapeutic devices.
MMDI’s Rebound HRD(R) Receives Separate Reimbursement Procedure Coding for Laparoscopic Inguinal Hernia Repair
MINNEAPOLIS, Minn. (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the Centers for Medicare & Medicaid Services (CMS) have agreed to create seven new ICD-9-CM reimbursement procedure codes for its new Rebound HRD (Hernia Repair Device). The new coding will become effective October 1, 2008. The Rebound HRD was recently FDA 510(k) cleared and is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects.
MMDI’s Rebound HRD(TM) Receives FDA 510(k) Clearance
MINNEAPOLIS, Minn. – Aug. 21 (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its new Rebound HRD(TM) (Hernia Repair Device). The Rebound HRD is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects where weakness exists and where the support of a nonabsorbable material is preferred.